Total testosterone |
>200 ng/dL |
Hypogonadism |
Chemiluminescence assay |
Thyroid-stimulating hormone |
<5 μIU/mL |
Primary hypothyroidism |
Chemiluminescence assay |
Creatinine (and calculated estimated glomerular filtration rate) |
<1.5 mg/dL (>60 mL/min) |
Renal impairment |
Jaffe enzymatic assay |
Creatine kinase |
<5000 U/L |
Rhabdomyolysis, other myositis |
Calorimetric activity assay; International Federation of Clinical Chemistry |
Erythrocyte sedimentation rate |
<25 mm/h |
Inflammation and other disorders (high negative predictive value) |
Automated spontaneous sedimentation method |
Ultrasensitive C-reactive protein |
<3 mg/dL |
Infections, inflammation, cardiovascular risk |
Latex-intensified immunoturbidimetry |
Hematocrit |
36%–54% |
Anemia from several causes, polycythemia |
Automated assay |
Neutrophils |
1000–9000/mm3
|
Infections, aplasia, neutropenic disorders |
Automated assay |
Alanine aminotransferase |
<50 U/L |
Liver dysfunctions |
Calorimetric activity assays |
Aspartate aminotransferase |
<50 U/L |
Liver dysfunctions, myolysis |
Calorimetric activity assays |
Vitamin B12
|
>180 pg/mL |
Neuropsychiatric symptoms from vitamin B12 deficiency |
Chemiluminescence assay |
Fasting glucose |
<100 mg/dL |
Prediabetes and diabetes |
Enzymatic assay of hexokinase |